Live Breaking News & Updates on Prnewswire Immix Biopharma Inc

Stay updated with breaking news from Prnewswire immix biopharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ImmixBio Announces FDA Orphan Drug Designation for IMX-110 for the Treatment of Soft Tissue Sarcoma

ImmixBio Announces FDA Orphan Drug Designation for IMX-110 for the Treatment of Soft Tissue Sarcoma
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Gabriel Morris , Immix Biopharma Inc , Normalization Technology , Prnewswire Immix Biopharma Inc , Drug Administration , Htm Technology , Office Of Orphan Products Development , Tissue Specific Therapeutics , Orphan Products Development , Drug Designation , Ilya Rachman , Immixbio Founder , Immixbio Chief Financial Officer , System Multi Action Regulators , Immix Biopharma ,

ImmixBio Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate Combination of IMX-110 and Tislelizumab in Solid Tumors

ImmixBio Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate Combination of IMX-110 and Tislelizumab in Solid Tumors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Ilya Rachman , Gabriel Morris , Prnewswire Immix Biopharma Inc , Beigene Ltd , Immix Biopharma Inc , Exchange Commission , China National Medical Products Administration , Normalization Technology , Tissue Specific , Tissue Specific Therapeutics , North America , System Multi Action Regulators , Securities Litigation Reform Act ,